Guidance for Industry: Use of Water by Food Manufacturers in Areas Subject to a Boil-Water Advisory; Availability, 26967-26968 [2010-11450]
Download as PDF
26967
Federal Register / Vol. 75, No. 92 / Thursday, May 13, 2010 / Notices
TABLE 2.—ESTIMATED ANNUAL RECORDKEEPING BURDEN1
21 CFR Section
No. of
Recordkeepers
Annual Frequency
of Recordkeeping
Total Annual
Records
Hours per
Record
Total Hours
1002.30 and 1002.31(a)
1,150
1,655.5
1,903,825
0.12
228,459
1002.40 and 1002.41
2,950
49.2
145,140
0.05
7,257
1020.30(g)
22
1
22
0.5
11
1040.10(a)(3)(ii)
40
1
40
1.0
40
Totals
1 There
235,767
are no capital costs or operating and maintenance costs associated with this collection of information.
The burden estimates were derived by
consultation with FDA and industry
personnel, and are based on actual data
collected from industry. An evaluation
of the type and scope of information
requested was also used to derive some
time estimates. For example, disclosure
information primarily requires time
only to update and maintain existing
manuals. Initial development of
manuals has been performed except for
new firms entering the industry.
The following information collection
requirements are not subject to review
by OMB because they do not constitute
a ‘‘collection of information’’ under the
PRA: Sections 1002.31(c); 1003.10(a),
(b), and (c); 1003.11(a)(3) and (b);
1003.20(a) through (h); 1003.21(a)
through (d); 1003.22(a) and (b);
1003.30(a) and (b); 1003.31(a) and (b);
1004.2(a) through (i); 1004.3(a) through
(i); 1004.4(a) through (h); 1005.21(a)
through (c); and 1005.22(b). These
requirements apply to the collection of
information during the conduct of
general investigations or audits (5 CFR
1320.4(b)).
The following labeling requirements
are also not subject to review under the
PRA because they are a public
disclosure of information originally
supplied by the Federal Government to
the recipient for the purpose of
disclosure to the public (5 CFR
1320.3(c)(2)): Sections 1020.10(c)(4),
1030.10(c)(6), 1040.10(g), 1040.30(c)(1),
and 1050.10(d)(1).
Dated: May 7, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
sroberts on DSKD5P82C1PROD with NOTICES
[FR Doc. 2010–11396 Filed 5–12–10; 8:45 am]
BILLING CODE 4160–01–S
VerDate Mar<15>2010
15:56 May 12, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0236]
Guidance for Industry: Use of Water by
Food Manufacturers in Areas Subject
to a Boil-Water Advisory; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of a guidance entitled
‘‘Guidance for Industry: Use of Water by
Food Manufacturers in Areas Subject to
a Boil-Water Advisory.’’ This guidance
is intended to advise food
manufacturers that once a boil-water
advisory has been issued they should
stop using the water subject to the
advisory until the water again meets the
applicable Federal and State drinking
water quality standards. Further, this
guidance is intended to assist food
manufacturers in evaluating food that
already was produced with water
subject to the advisory. The guidance is
in response to the recent major water
pipe break in Massachusetts that
interrupted service to 30 Massachusetts
Water Resources Authority (MWRA)
customer communities (serving
approximately 2 million residents).
DATES: Submit electronic or written
comments on the guidance at any time.
ADDRESSES: Submit electronic
comments on the guidance to https://
www.regulations.gov. Submit written
comments on the guidance to the
Division of Dockets Management
(HFA—305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
written requests for single copies of the
guidance to the Office of Food Safety,
Center for Food Safety and Applied
Nutrition (HFS–300), Food and Drug
Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740. Send
SUMMARY:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
two self-addressed adhesive labels to
assist that office in processing your
request. See the SUPPLEMENTARY
INFORMATION section for electronic
access to the guidance.
FOR FURTHER INFORMATION CONTACT:
Jenny Scott, Center for Food Safety and
Applied Nutrition (HFS–300), Food and
Drug Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 301–
436–1700
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of
a guidance entitled ‘‘Guidance for
Industry: Use of Water by Food
Manufacturers in Areas Subject to a
Boil-Water Advisory.’’ This guidance is
intended to advise food manufacturers
that once a boil-water advisory has been
issued they should stop using the water
subject to the advisory until the water
again meets the applicable Federal and
State drinking water quality standards.
Further, this guidance is intended to
assist food manufacturers in evaluating
food that already was produced with
water subject the advisory.
FDA is issuing this guidance as Level
1 guidance consistent with FDA’s good
guidance practices regulation (21 CFR
10.115). Consistent with FDA’s good
guidance practices regulation, the
agency will accept comment, but is
implementing the guidance document
immediately in accordance with 21 CFR
10.115(g)(2) because the agency has
determined that prior public
participation is not feasible or
appropriate in light of the need to
respond expeditiously to the recent
major water pipe break in Massachusetts
that interrupted service to 30 MWRA
customer communities (serving
approximately 2 million residents). The
guidance represents the agency’s current
thinking on the use of water by food
manufacturers in areas subject to a
‘‘Boil-Water Advisory.’’ It does not create
or confer any rights for or on any person
and does not operate to bind FDA or the
public. An alternate approach may be
E:\FR\FM\13MYN1.SGM
13MYN1
26968
Federal Register / Vol. 75, No. 92 / Thursday, May 13, 2010 / Notices
used if such approach satisfies the
requirements of the applicable statutes
and regulations.
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) electronic or written
comments regarding the guidance.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
III. Electronic Access
Persons with access to the Internet
may obtain the draft guidance at https://
www.fda.gov/FoodGuidances or https://
www.regulations.gov.
Dated: May 10, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
Bethesda, MD 20892, 301–451–2020,
kenshalod@nei.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Eye Institute
Special Emphasis Panel; SBIR Grant
Application.
Date: May 20, 2010.
Time: 12 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Eye Institute, 5635 Fishers
Lane, Suite 1300, Rockville, MD 20892.
Contact Person: Samuel Rawlings, PhD,
Chief, Scientific Review Branch, Division Of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300 MSC 9300,
Bethesda, MD 20892–9300, 301–451–2020,
rawlings@nei.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
May 6, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–11450 Filed 5–10–10; 4:15 pm]
BILLING CODE 4160–01–S
[FR Doc. 2010–11307 Filed 5–12–10; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
National Institutes of Health
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Eye Institute; Notice of Closed
Meetings
National Institutes of Health
sroberts on DSKD5P82C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Loan
Repayment Grants.
Date: May 18–19, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Eye Institute, 5635 Fishers
Lane, Bethesda, MD (Virtual Meeting).
Contact Person: Daniel R. Kenshalo, PhD,
Scientific Review Officer, National Eye
Institute, National Institutes of Health, 5635
Fishers Lane, Suite 1300, MSC 9300,
VerDate Mar<15>2010
17:43 May 12, 2010
Jkt 220001
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Adult
Brain Tumor Consortium.
Date: May 20, 2010.
Time: 1 p.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Place: National Institutes of Health, 6116
Executive Boulevard, Room 6006, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Gerald G. Lovinger, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Blvd., Room 8101, Bethesda, MD
20892–8329, 301/496–7987,
lovingeg@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to scheduling
conflicts.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Small
Grants Program for Cancer Epidemiology.
Date: June 17–18, 2010.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Joyce C. Pegues, B.S., B.A.,
PhD, Scientific Review Officer, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 6116 Executive Boulevard,
Room 7149, Bethesda, MD 20892–8329, 301–
594–1286, peguesj@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Innovative
Technology Development.
Date: June 23–24, 2010.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Jeffrey E. DeClue, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Boulevard, Room 8059,
Bethesda, MD 20892–8329, 301–496–7904,
decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Comprehensive Minority Institution Cancer
Center Partnership.
Date: June 29–30, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Lalita D. Palekar, PhD,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116
Executive Boulevard, Room 7141, Bethesda,
MD 20892, 301–496–7575,
palekarl@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Nanotechnology Imaging and Sensing
Platforms.
Date: June 29, 2010.
Time: 11 a.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Conference Room 707,
Rockville, MD 20852 (Telephone Conference
Call).
E:\FR\FM\13MYN1.SGM
13MYN1
Agencies
[Federal Register Volume 75, Number 92 (Thursday, May 13, 2010)]
[Notices]
[Pages 26967-26968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-11450]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-D-0236]
Guidance for Industry: Use of Water by Food Manufacturers in
Areas Subject to a Boil-Water Advisory; Availability
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a guidance entitled ``Guidance for Industry: Use of
Water by Food Manufacturers in Areas Subject to a Boil-Water
Advisory.'' This guidance is intended to advise food manufacturers that
once a boil-water advisory has been issued they should stop using the
water subject to the advisory until the water again meets the
applicable Federal and State drinking water quality standards. Further,
this guidance is intended to assist food manufacturers in evaluating
food that already was produced with water subject to the advisory. The
guidance is in response to the recent major water pipe break in
Massachusetts that interrupted service to 30 Massachusetts Water
Resources Authority (MWRA) customer communities (serving approximately
2 million residents).
DATES: Submit electronic or written comments on the guidance at any
time.
ADDRESSES: Submit electronic comments on the guidance to https://www.regulations.gov. Submit written comments on the guidance to the
Division of Dockets Management (HFA--305), Food and Drug
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
Submit written requests for single copies of the guidance to the Office
of Food Safety, Center for Food Safety and Applied Nutrition (HFS-300),
Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD
20740. Send two self-addressed adhesive labels to assist that office in
processing your request. See the SUPPLEMENTARY INFORMATION section for
electronic access to the guidance.
FOR FURTHER INFORMATION CONTACT: Jenny Scott, Center for Food Safety
and Applied Nutrition (HFS-300), Food and Drug Administration, 5100
Paint Branch Pkwy., College Park, MD 20740, 301-436-1700
SUPPLEMENTARY INFORMATION:
I. Background
FDA is announcing the availability of a guidance entitled
``Guidance for Industry: Use of Water by Food Manufacturers in Areas
Subject to a Boil-Water Advisory.'' This guidance is intended to advise
food manufacturers that once a boil-water advisory has been issued they
should stop using the water subject to the advisory until the water
again meets the applicable Federal and State drinking water quality
standards. Further, this guidance is intended to assist food
manufacturers in evaluating food that already was produced with water
subject the advisory.
FDA is issuing this guidance as Level 1 guidance consistent with
FDA's good guidance practices regulation (21 CFR 10.115). Consistent
with FDA's good guidance practices regulation, the agency will accept
comment, but is implementing the guidance document immediately in
accordance with 21 CFR 10.115(g)(2) because the agency has determined
that prior public participation is not feasible or appropriate in light
of the need to respond expeditiously to the recent major water pipe
break in Massachusetts that interrupted service to 30 MWRA customer
communities (serving approximately 2 million residents). The guidance
represents the agency's current thinking on the use of water by food
manufacturers in areas subject to a ``Boil-Water Advisory.'' It does
not create or confer any rights for or on any person and does not
operate to bind FDA or the public. An alternate approach may be
[[Page 26968]]
used if such approach satisfies the requirements of the applicable
statutes and regulations.
II. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) electronic or written comments regarding the guidance.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.
III. Electronic Access
Persons with access to the Internet may obtain the draft guidance
at https://www.fda.gov/FoodGuidances or https://www.regulations.gov.
Dated: May 10, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010-11450 Filed 5-10-10; 4:15 pm]
BILLING CODE 4160-01-S